In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Preoperative Spinal Tumor Embolization: An Institutional Experience

    Final Number:
    1280

    Authors:
    George M. Ghobrial MD; Nohra Chalouhi MD; James S. Harrop MD, FACS; Richard T. Dalyai MD; Stavropoula I. Tjoumakaris MD; L. Fernando Gonzalez MD; Aaron S. Dumont MD; David M. Hasan MD; Robert H. Rosenwasser MD, FACS, FAHA; Pascal Jabbour MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Preoperative embolization has the potential to decrease intraoperative blood loss and facilitate spinal cord decompression and tumor resection .

    Methods: A retrospective case review was conducted on patients undergoing preoperative transarterial embolization of a spinal tumor between 1995 and 2012 at our institution.

    Results: 30 patients met the inclusion criteria, with a mean age of 60.6 years. Twenty-eight patients had metastatic tumors and 2 patients had hemangiomas. In 14 (50%) patients the metastases were from renal cell carcinomas. 54 vessels were embolized using PVA, NBCA, Onyx, coils, or embospheres. Sixteen patients were treated with Onyx, 6 patients with PVA, 3 patients with embospheres, 2 patients with NBCA, and 3 patients with a combination of embolic agents. The average decrease in tumor blush was 97.8% with Onyx versus 92.6% with the rest of the embolic agents (p=0.08). The estimated blood loss was 1616 ml (range 350-5000 ml). Blood loss was 1385 cc on average with Onyx versus 1763 with the rest of the embolic agents (p=0.5). The mean length of stay was 16 days. The mortality rate was zero. Pre- and post-operative modified Rankin Score (mRS) did not differ significantly in the series (3.12 vs. 3.10, respectively, p=0.9).

    Conclusions: In our experience, the use of transarterial tumor embolization as an adjunct for spinal surgery is safe and effective.

    Patient Care: To promote awareness of the safety and efficacy of preoperative embolization of spinal tumors in hopes to lower the morbidity of spinal surgery, particularly intraoperative blood loss.

    Learning Objectives: At the conclusion of this presentation, the reader will be familiar with: the use of endovascular embolization of hypervascular extradural spinal tumors with several embolic agents.

    References: Ashour R, Aziz-Sultan MA, Soltanolkotabi M, Schoeneman SE, Alden TD, Hurley MC, et al: Safety and efficacy of onyx embolization for pediatric cranial and spinal vascular lesions and tumors. Neurosurgery 71:773-784, 2012 Berkefeld J, Scale D, Kirchner J, Heinrich T, Kollath J: Hypervascular spinal tumors: influence of the embolization technique on perioperative hemorrhage. AJNR Am J Neuroradiol 20:757-763, 1999 Bilsky MH, Lis E, Raizer J, Lee H, Boland P: The diagnosis and treatment of metastatic spinal tumor. Oncologist 4:459-469, 1999

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy